Sign In
Buy MSD
$7.34
+0.0400 (+0.548%)
At Close: Jun 18, 2026
Certain Morgan Stanley Closed-End Funds Declare Quarterly Dividends
04:00pm, Thursday, 18'th Jun 2026
NEW YORK--(BUSINESS WIRE)--Each of the Morgan Stanley closed-end funds listed below (the “Funds”) today declared the following dividends. RECORD DATE PAYABLE DATE 6/30/26 7/15/26 Name of Closed-En
Keysight Accelerates the Future of Automotive Emergency Communications with Hybrid eCall Certification
11:00am, Monday, 01'st Jun 2026
[url="]Keysight Technologies, Inc.[/url] (NYSE: KEYS) today announced it has achieved a Hybrid eCall certification to the EN 18052:2025 standard from DEKRA. Th
MSD: Best To Avoid For Now And To Reconsider An Entry Point Next Year
08:58am, Wednesday, 25'th Mar 2026
Morgan Stanley Emerging Markets Debt Fund has rallied since 2022, driven by rising rates, macro improvements, and a weaker US dollar. MSD offers high-yield and diversified exposure to sovereign, corpo
Certain Morgan Stanley Closed-End Funds Declare Quarterly Dividends
04:00pm, Friday, 20'th Mar 2026
NEW YORK--(BUSINESS WIRE)--Each of the Morgan Stanley closed-end funds listed below (the “Funds”) today declared the following dividends. RECORD DATE PAYABLE DATE 3/31/2026 4/15/2026 Name of Close
Evaxion provides update on MSD collaboration - retains global rights to Gonorrhea vaccine candidate EVX-B2
07:00am, Friday, 19'th Dec 2025
COPENHAGEN, Denmark, December 19, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, has been informed th
Certain Morgan Stanley Closed-End Funds Declare Year-End Dividends
04:00pm, Tuesday, 09'th Dec 2025
NEW YORK--(BUSINESS WIRE)--Each of the Morgan Stanley closed-end funds listed below (the “Funds”) today declared the following dividends. RECORD DATE PAYABLE DATE 12/19/25 1/15/26 Name of
Citi Trends Posts HSD Comps Over MSD Comps, But The Stock Is Years Ahead Fundamentals
07:34am, Tuesday, 09'th Dec 2025
Citi Trends delivered its fifth consecutive quarter of positive comps, underscoring sustained operational momentum and effective merchandising. CTRN projects 2027 sales of $900 million and EBITDA of $
10 Best CEFs This Month: Average Yield Of 9% Plus (October 2025)
08:15am, Sunday, 26'th Oct 2025
This month's top 10 closed-end funds offer an average yield of 9.25% and strong long-term performance across diverse asset classes. For income investors, closed-end funds remain an attractive investme
The Chemist's Triple-Factor Closed-End Fund Report, October 2025
07:54am, Saturday, 25'th Oct 2025
The Triple-Factor CEF Report screens over 400 funds for high yield (>6.5%), strong coverage (>90%), and discount to NAV, balancing yield, sustainability, and value. Top lists include funds with widest
Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales
04:05pm, Monday, 06'th Oct 2025
LONDON and RALEIGH, N.C., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a biopharmaceutical company focused on respiratory diseases, which entered into a de
Certain Morgan Stanley Closed-End Funds Declare Quarterly Dividends
04:30pm, Friday, 19'th Sep 2025
NEW YORK--(BUSINESS WIRE)--Each of the Morgan Stanley closed-end funds listed below (the “Funds”) today declared the following dividends. RECORD DATE PAYABLE DAT
MākuSafe Named 2025 MSD Solutions Lab Safety Innovation Challenge Winner
03:00pm, Friday, 19'th Sep 2025
Tech innovators present solutions to tackle top workplace injury at NSC Safety Congress & Expo DENVER , Sept. 19, 2025 /PRNewswire/ -- The National Safety Council showcased 10 breakthrough technologi
MSD: Not As Well-Positioned As Its Peers And Likely To Continue Underperforming
05:08pm, Monday, 15'th Sep 2025
MS Emerging Markets Debt Fund currently yields 10.11%, higher than most peers and indices, but is heavily invested in U.S. dollar-denominated bonds. MSD's recent underperformance is attributed to U.S.
Flexsteel Grows Albeit Decelerating, And Tariffs Are About To Impact Sales
12:10pm, Friday, 22'nd Aug 2025
Flexsteel presented very good 4Q25 (calendar 2Q25) results, with MSD growth in topline and operating margin leverage. However, growth is consistently decelerating, and the company might face more chal
MSD: EM Spreads Are Tight, Will Not Benefit From Any Dollar Depreciation
11:30am, Monday, 30'th Jun 2025
MSD is not a good hedge against a weaker dollar, as it primarily holds USD-denominated emerging market debt. The fund now trades at a rare premium to NAV, with stretched valuations and historically ti
